Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where BDSX declined for three days, in 279 of 309 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.
The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BDSX as a result. In 76 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.
The Moving Average Convergence Divergence Histogram (MACD) for BDSX turned negative on October 01, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 42 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 88%.
BDSX moved below its 50-day moving average on October 08, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for BDSX crossed bearishly below the 50-day moving average on October 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 83%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +6.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where BDSX advanced for three days, in 198 of 233 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
BDSX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 182 of 198 cases where BDSX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. BDSX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 47 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (27.543) is normal, around the industry mean (64.051). P/E Ratio (-7.700) is within average values for comparable stocks, (1.569). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (2.463) is also within normal values, averaging (9.775).
The Tickeron PE Growth Rating for this company is 65 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BDSX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.
The Stochastic Oscillator for ELMD moved into oversold territory on October 20, 2026. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ELMD's RSI Oscillator exited the oversold zone, 19 of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 70%.
The Moving Average Convergence Divergence (MACD) for ELMD just turned positive on September 17, 2026. Looking at past instances where ELMD's MACD turned positive, the stock continued to rise in 28 of 41 cases over the following month. The odds of a continued upward trend are 68%.
Following a +1.61% 3-day Advance, the price is estimated to grow further. Considering data from situations where ELMD advanced for three days, in 183 of 258 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
The Momentum Indicator moved below the 0 level on October 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ELMD as a result. In 74 of 118 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 63%.
The 50-day moving average for ELMD moved below the 200-day moving average on October 16, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ELMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.
The Aroon Indicator for ELMD entered a downward trend on September 25, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 42 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 56 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating steady price growth. ELMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 77 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 100 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.253) is normal, around the industry mean (2.979). P/E Ratio (20.029) is within average values for comparable stocks, (2.590). ELMD's Projected Growth (PEG Ratio) (103.010) is very high in comparison to the industry average of (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (3.080) is also within normal values, averaging (40.124).
BDSX | ELMD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 76 | 88 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 47 Fair valued | 100 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 56 | |
SMR RATING 1..100 | 100 | 42 | |
PRICE GROWTH RATING 1..100 | 35 | 58 | |
P/E GROWTH RATING 1..100 | 65 | 77 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BDSX's Valuation (47) in the null industry is somewhat better than the same rating for ELMD (100) in the Medical Specialties industry. This means that BDSX’s stock grew somewhat faster than ELMD’s over the last 12 months.
ELMD's Profit vs Risk Rating (56) in the Medical Specialties industry is somewhat better than the same rating for BDSX (100) in the null industry. This means that ELMD’s stock grew somewhat faster than BDSX’s over the last 12 months.
ELMD's SMR Rating (42) in the Medical Specialties industry is somewhat better than the same rating for BDSX (100) in the null industry. This means that ELMD’s stock grew somewhat faster than BDSX’s over the last 12 months.
BDSX's Price Growth Rating (35) in the null industry is in the same range as ELMD (58) in the Medical Specialties industry. This means that BDSX’s stock grew similarly to ELMD’s over the last 12 months.
BDSX's P/E Growth Rating (65) in the null industry is in the same range as ELMD (77) in the Medical Specialties industry. This means that BDSX’s stock grew similarly to ELMD’s over the last 12 months.
| BDSX | ELMD | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 70% |
| Stochastic ODDS (%) | 1 day ago 89% | 1 day ago 81% |
| Momentum ODDS (%) | 1 day ago 89% | 1 day ago 63% |
| MACD ODDS (%) | 1 day ago 88% | 3 days ago 68% |
| TrendWeek ODDS (%) | 1 day ago 88% | 1 day ago 62% |
| TrendMonth ODDS (%) | 1 day ago 90% | 1 day ago 70% |
| Advances ODDS (%) | 17 days ago 85% | 23 days ago 71% |
| Declines ODDS (%) | 3 days ago 90% | 3 days ago 66% |
| BollingerBands ODDS (%) | 1 day ago 86% | N/A |
| Aroon ODDS (%) | 1 day ago 90% | 1 day ago 61% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BDSX’s FA Score shows that 0 FA rating(s) are green while ELMD’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BDSX’s TA Score shows that 4 TA indicator(s) are bullish while ELMD’s TA Score has 4 bullish TA indicator(s).
BDSX (@Medical Specialties) experienced а -4.52% price change this week, while ELMD (@Medical/Nursing Services) price change was -0.87% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -1.12%. For the same industry, the average monthly price growth was -4.99%, and the average quarterly price growth was +43.90%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.88%. For the same industry, the average monthly price growth was -9.59%, and the average quarterly price growth was -10.00%.
BDSX is expected to report earnings on Nov 02, 2026.
ELMD is expected to report earnings on Nov 11, 2026.
Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Medical/Nursing Services (-2.88% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BBAX | 62.26 | 0.62 | +1.01% |
| JPMorgan BetaBuilders Developed Asia Pacific ex-Japan ETF (BBAX) | |||
| CWEB | 18.04 | 0.17 | +0.95% |
| Direxion Daily CSI China Internet Index Bull 2X ETF (CWEB) | |||
| FIIG | 19.83 | 0.03 | +0.15% |
| First Trust Intermediate Duration Investment Grade Corporate ETF (FIIG) | |||
| ACGR | 70.52 | N/A | N/A |
| American Century Large Cap Growth ETF (ACGR) | |||
| KYLD | 19.07 | -0.02 | -0.10% |
| Kurv High Income ETF | |||
A.I.dvisor indicates that over the last year, ELMD has been loosely correlated with KRMD. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ELMD jumps, then KRMD could also see price increases.
| Ticker / NAME | Correlation To ELMD | 1D Price Change % | ||
|---|---|---|---|---|
| ELMD | 100% | +0.15% | ||
| KRMD - ELMD | 34% Loosely correlated | +0.66% | ||
| SMTI - ELMD | 32% Poorly correlated | N/A | ||
| INBS - ELMD | 31% Poorly correlated | +9.15% | ||
| KIDS - ELMD | 31% Poorly correlated | +6.67% | ||
| SIBN - ELMD | 30% Poorly correlated | +4.48% | ||
More | ||||